Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07554508
Belzutifan VHL RCC HK Prospective Registry
Sponsor: Chinese University of Hong Kong
View on ClinicalTrials.gov
Summary
This study aims to evaluate the Belzutifan's efficacy, drug safety, disease course, and the health-economic impact of the treatment to Von Hippel-Lindau (VHL) syndrome.
Official title: A Prospective Registry for Belzutifan in the Treatment of Von Hippel-Lindau (VHL) Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-05
Completion Date
2029-03-31
Last Updated
2026-04-28
Healthy Volunteers
No
Conditions
Locations (1)
Prince of Wales Hospital
Shatin, Hong Kong